Statistics: It's Essential
July 29 - August 3, 2017
Baltimore Convention Center
JSM 2017 Online Program
Keyword Search
Legend:
CC
= Baltimore Convention Center,
H
= Hilton Baltimore
* = applied session ! = JSM meeting theme
Keyword Search Criteria:
drug development
returned 9 record(s)
Monday, 07/31/2017
Open-Source Programming in the Regulated Environment
Greg Valin, Amgen
Analytical Framework for Safety Assessment Committee (SAC) in Drug Development
Amit Bhattacharyya, ACI Clinical; Jonathan Seltzer, ACI Clinical
9:50 AM
Tuesday, 08/01/2017
Benefit-Risk Analysis in Medical Development
Shuai Yuan, Merck
Expert Prior Elicitations in Practice
Michael Sonksen, Eli Lilly and Company
2:25 PM
PRO-CTCAE in Oncology Clinical Trials: a U.S. Regulatory Perspective
Paul Kluetz, U.S. Food and Drug Administration
2:45 PM
Wednesday, 08/02/2017
Statistical Inference in the Era of Precision Medicine- the Essential Role of Statistics for Unmet Needs in Algorithm Refinement, Diagnostics Application and Drug Development
Ruixiao Lu, Genomic Health
A Case Study Exploration of MTPI and Proposed Methods to Expand to Combination Drug Development
Matthew Gribbin, MedImmune; Nairouz Elgeioushi, MedImmune
10:35 AM
Drug Development Planning and CDISC Standards from the Perspective of a Programmer/Analyst
Michael Carniello, Astellas Pharma
2:05 PM
Interplay Between Estimands and Missing Data in Clinical Trials
David Ohlssen, Novartis
2:05 PM
